Yu et al. found that CXCR4 could affect the prognosis of patients with colorectal cancer through downstream signalling molecule‐mediated inflammatory responses, again suggesting that it might be a potential therapeutic target.34 The gene discussed is CXCR4; the disease is colorectal cancer.